ETHER LYSOPHOSPHOLIPID-INDUCED PRODUCTION OF PLATELET-ACTIVATING-FACTOR IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES

被引:69
作者
SUGIURA, T
FUKUDA, T
MASUZAWA, Y
WAKU, K
机构
[1] Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa
关键词
PAF; LYSO-PAF; ETHER PHOSPHOLIPID; ACETYLTRANSFERASE; (HUMAN POLYMORPHONUCLEAR LEUKOCYTE);
D O I
10.1016/0005-2760(90)90520-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human polymorphonuclear leukocytes (PMN) produced considerable amounts of platelet-activating factor (PAF) when exposed to various concentrations of lyso-PAF, especially in the absence of albumin. The amount of produced PAF in the presence of 5 mu-M lyso-PAF (without albumin) was 1.1 pmol/10 min per 2.5.10(6) cells, which was close to the level in the case of opsonized zymosan stimulation. We found that the activity of neither acetyltransferase nor acetylhydrolase was affected markedly by the treatment of cells with lyso-PAF, suggesting that the increased availability of lyso-PAF could be responsible for the induction of PAF synthesis. We also found that PAF synthesis was induced not only by lyso-PAF but also by ether-containing ethanolamine lysophospholipids, 1-alkenyl(alkyl)-sn-glycero-3-phosphoethanolamine (GPE). The addition of 1-alkenyl(alkyl)-GPE caused the degradation of pre-existing 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (GPC) and an increased level of lyso-PAF, followed by the formation of PAF. By contrast, 1-acyl-GPC and 1-acyl-GPE failed to induce PAF production. These results suggest a possible key role of the availability of lyso-PAF in triggering the biosynthesis of PAF in human PMN.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 59 条
[51]   AUGMENTED PRODUCTION OF PLATELET-ACTIVATING FACTOR IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY KETONE-BODIES [J].
SUGIURA, T ;
OJIMAUCHIYAMA, A ;
MASUZAWA, Y ;
WAKU, K .
FEBS LETTERS, 1989, 258 (02) :351-354
[52]  
SUGIURA T, 1987, J BIOL CHEM, V262, P1199
[53]  
SUGIURA T, 1988, J BIOL CHEM, V263, P17490
[54]   IS PLATELET ACTIVATING FACTOR (PAF) A MEDIATOR OF ENDOTOXIN-SHOCK [J].
TERASHITA, Z ;
IMURA, Y ;
NISHIKAWA, K ;
SUMIDA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 109 (02) :257-261
[55]  
TESSNE RTG, 1987, J BIOL CHEM, V262, P12660
[56]  
TESSNER TG, 1989, J BIOL CHEM, V264, P4794
[57]   INVOLVEMENT OF CIRCULATING PHOSPHOLIPASE-A2 IN THE PATHOGENESIS OF THE HEMODYNAMIC-CHANGES IN ENDOTOXIN-SHOCK [J].
VADAS, P ;
HAY, JB .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1983, 61 (06) :561-566
[58]  
WOODARD DS, 1987, J BIOL CHEM, V262, P2520
[59]  
WYKLE RL, 1980, J BIOL CHEM, V255, P256